Dr. Thomas MacDonald Presents: TIME – The Treatment in Morning versus Evening study August 26, 2022 Disclosures: TBA
Dr. Michael Mack and Dr. C. Michael Gibson discuss the STAR-T/D trials in which a column of microbeads attached to the bypass pump are used to remove ticagrelor, rivaroxaban, and apixaban May 25, 2022 Disclosures: TBA
Dr. Kausik Ray and Dr. C. Michael Gibson Discuss: Non-LDL Lipid Lowering Targets for Event Reduction May 13, 2022 Disclosures: TBA
Dr. Kausik Ray and Dr. C. Michael Gibson Discuss: Reimagining Prevention from a Public Healthcare Perspective May 12, 2022 Disclosures: TBA
Dr. Kausik Ray and Dr. C. Michael Gibson Discuss: The Verve Therapeutics Gene Editing Approach to Lowering LDL in Familial Hypercholesterolemia May 10, 2022 Disclosures: TBA
Dr. Paul Ridker and Dr. C. Michael Gibson Discuss: Secondary Analysis Of The CANTOS Trial: Differential Impact Of Residual Inflammatory Risk And Residual Cholesterol Risk Among Atherosclerosis Patients With And Without Chronic Kidney Disease April 4, 2022 Disclosures: TBA
Dr. Felix Mahfoud and Dr. C. Michael Gibson Discuss: 3-year Efficacy Outcomes From The Spyral Htn-on Med Pilot Study: Long Term Effect Of Renal Denervation On Blood Pressure Reduction In Patients On Antihypertension Medications April 4, 2022 Disclosures: TBA
Dr. Mehdi Shishehbor and Dr. Serge Korjian Discuss: A Randomized Trial To Confirm The Safety And Effectiveness Of Chocolate Touch Paclitaxel Coated PTA Balloon Catheter In Above The Knee Lesions April 4, 2022 Disclosures: TBA
Dr. Marie-Sophie De Koning and Dr. C. Michael Gibson Discuss: GIPS-IV: The Groningen Intervention Study For The Preservation Of Cardiac Function With Sodium Thiosulfate After St-segment Elevation Myocardial Infarction April 4, 2022 Disclosures: TBA
Dr. Bon-Kwon Koo and Dr. C. Michael Gibson Discuss: The FLAVOUR Randomized Clinical Trial: Comparison Of Fractional Flow Reserve-guided And Intravascular Ultrasound-guided Percutaneous Coronary Intervention In Intermediate Coronary Artery Stenosis April 4, 2022 Disclosures: TBA
